Vaccine for Covid-19 Infection

Jamshed Akhtar

Jamshed Akhtar Department of Paediatric Surgery National Institute of Child Health Jinnah Sindh Medical University (JSMU) Karachi

Abstract

With the availability of vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection healthcare providers may expect some relief in their workplace. Though process of development of vaccine and their emergency use approval with limited evidence based data raises doubts, but till date this appears to be a way forward in dealing with Covid-19 infection.1WHO has recently given the emergency use approval in late December 2020.2Currently two vaccines are approved of vaccine for general use which include those developed by Pfizer-BioNTech and Moderna.2 These are mRNA type of vaccines. There are other vaccines currently undergoing phase 3 trials that include Oxford/AstraZeneca, Chinese CanSino covid and Sinopharm vaccines. Chinese vaccines are undergoing trials in Pakistan and Sinopharm vaccine is expected to be used by the Pakistani government in first quarter of 2021. Same vaccine is already in use in United Arab Emirates after clinical trials………………